Cited by 354Epigenetics and DNA MethylationBRCA gene mutations in cancerBreast Lesions and Carcinomas

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

Catteau, Aurélie, Harris, William H, Xu, Chun-Fang, Solomon, Ellen·1999·Oncogene

Abstract

Reduced expression of BRCA1 has been reported in sporadic breast cancer, although the mechanisms underlying this phenomenon remain unclear. Abnormal methylation leading to silencing of tumour suppressor genes has been implicated in tumorigenesis in a wide range of sporadic cancers. Therefore, we sought to determine the frequency of methylation within the BRCA1 promoter region in a large group of sporadic invasive breast (n =96) and ovarian (n = 43) carcinomas using Southern analyses. Overall, methylation was detected in 11% of breast cancer cases and in 5% of ovarian tumours. Methylation of the BRCA1 promoter region was strongly correlated with lack of estrogen and progesterone receptor expression. It is clear from the frequency of abnormal methylation of the BRCA1 promoter region, that this cannot be the sole mechanism mediating the reduced expression of BRCA1 that has previously been reported to occur in the majority of invasive sporadic breast tumours. Nevertheless this study suggests that abnormal methylation of the BRCA1 promoter may be important in tumorigenesis in a subset of sporadic breast and ovarian cancers.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1202509

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mutations outside the reading frame or promoter methylation changes could alter FANCJ expression and contribute to tumorigenesis.

    “Given that changes in BRCA1 promoter status contribute to sporadic tumors [64,65], mutations outside the reading frame or changes in promoter methylation status could alter FANCJ expression and contribute to tumorigenesis.”
  • Changes in BRCA1 promoter status contribute to sporadic tumors.

    “Given that changes in BRCA1 promoter status contribute to sporadic tumors [64,65], mutations outside the reading frame or changes in promoter methylation status could alter FANCJ expression and contribute to tumorigenesis.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Catteau, A., Harris, W. H., Xu, C.-F., & Solomon, E.
Affiliations
Guy's Hospital (GB)
Venue
Oncogene
Published
1999-03-18
Volume
18
Issue
11
Pages
1957-1965
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2036245489
Cited by
354
References
33
Citations by year
2026: 1 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 3 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 11 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 22 · 2012: 18
FWCI
8.44
Type
journal article
Language
en
Open access
closed
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
Israel Cancer Research Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Keywords
BRCA1, promoter methylation, sporadic breast cancer, ovarian cancer, tumor suppressor gene silencing, estrogen receptor, progesterone receptor, carcinogenesis, DNA methylation
MeSH terms
Adult, Aged, Breast Neoplasms, Female, Humans, Middle Aged, Ovarian Neoplasms, Promoter Regions, Genetic, DNA Methylation, BRCA1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review